Source comparison
5-Amino-1MQ vs MOTS-c: Research Application Comparison
Primary Mechanism NNMT enzyme inhibition AMPK activation via mitochondrial-nuclear signaling Different entry points into metabolic regulation. Choose based on pathway of interest NAD+ Modulation Increases NAD+ by preventing nicotinamide methylation Does not di
This comparison does not assign a generated winner or score.
- Primary Mechanism
- NNMT enzyme inhibition
- AMPK activation via mitochondrial-nuclear signaling
- Different entry points into metabolic regulation. Choose based on pathway of interest
- NAD+ Modulation
- Increases NAD+ by preventing nicotinamide methylation
- Does not directly affect NAD+ pools
- 5-Amino-1MQ is the tool for NAD+-focused research; MOTS-c for mitochondrial signaling
- Dosing in Rodent Models
- 50 mg/kg/day oral (Weill Cornell study)
- 5–15 mg/kg intraperitoneal 3x/week (USC studies)
- MOTS-c requires injection; 5-Amino-1MQ can be administered orally in animal models
- Effect on Appetite
- No reduction in food intake observed
- Both compounds work through metabolic rate changes, not appetite suppression
- Human Evidence
- None (preclinical only)
- Neither has completed clinical trials. Both remain investigational research tools
- Research Use Case
- NNMT biology, sirtuin pathway studies, NAD+ metabolism
- Mitochondrial retrograde signaling, AMPK activation, exercise metabolism, aging research
- Bottom line: mechanism dictates application. Not potency